DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsLowNeutral
Announced Fri, 15 May · 19:06 IST

Divi's Laboratories Limited has informed the Exchange about Schedule of earnings conference call.

Board & Shareholder Meetings View source PDF

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.2%1-day move
₹6758.00
prior close
₹6750.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.3-0.8-0.9+2.2+1.8+1.6+2.1+0.5+0.5-0.0+0.1+8.2
Up moveDown movePending
AI summary

Divi's Laboratories has announced the schedule for releasing its Q4FY26 audited financial results (quarter and year ended March 31, 2026) on May 23, 2026. Following the results release, the company's management will host an earnings conference call on the same day at 14:30 hrs IST to discuss financial performance. The call will be accessible via dial-in numbers or pre-registration through DiamondPass. A transcript of the call will be available on the company's website. This filing complies with SEBI Regulation 30 disclosure requirements.

Likely market impact

This is a routine scheduling announcement with no immediate impact on the stock. Investors and analysts should note the May 23 date to access Q4FY26 results and participate in the earnings call for insights into the company's performance.